GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intech Biopharm Ltd (ROCO:6461) » Definitions » Marketable Securities

Intech Biopharm (ROCO:6461) Marketable Securities : NT$255.10 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Intech Biopharm Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Intech Biopharm's Marketable Securities for the quarter that ended in Sep. 2024 was NT$255.10 Mil.

Intech Biopharm's annual Marketable Securities increased from Dec. 2021 (NT$115.00 Mil) to Dec. 2022 (NT$310.13 Mil) and increased from Dec. 2022 (NT$310.13 Mil) to Dec. 2023 (NT$520.40 Mil).

Intech Biopharm Marketable Securities Historical Data

The historical data trend for Intech Biopharm's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intech Biopharm Marketable Securities Chart

Intech Biopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.00 100.00 115.00 310.13 520.40

Intech Biopharm Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 220.45 520.40 520.45 255.15 255.10

Intech Biopharm Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Intech Biopharm  (ROCO:6461) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Intech Biopharm Marketable Securities Related Terms

Thank you for viewing the detailed overview of Intech Biopharm's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Intech Biopharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intech Biopharm Ltd (ROCO:6461) » Definitions » Marketable Securities
Comparable Companies
ROCO:4169 ROCO:6945 ROCO:1777 ROCO:6704 ROCO:4911 ROCO:6926 ROCO:4168 ROCO:6733 ROCO:6794 TPE:1762 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 36, Ruiguang Road, 3rd Floor, Lane 358, Neihu District, Taipei, TWN, 114
Website
https://www.intechbiopharm.com
Intech Biopharm Ltd is a biotechnology company. The company develops inhalation products including single or combination generic products and some new combinations or new formulation projects are under development. It develops drugs for the treatment of lung diseases such as asthma. It has operations in Taiwan, China, Hong Kong, and Others.

Intech Biopharm Headlines

No Headlines